Back to Search Start Over

Additional file 1 of Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....8e8bf20a739bbf6e4f01dc875dd03d8d
Full Text :
https://doi.org/10.6084/m9.figshare.19753316